-
1
-
-
77249086543
-
Fosfomycin: An old, new friend?
-
Popovic M, Steinort D, Pillai S, Joukhadar C. Fosfomycin: an old, new friend? Eur. J. Clin. Microbiol. Infect. Dis. 29(2), 127-142 (2010).
-
(2010)
Eur. J. Clin. Microbiol. Infect. Dis.
, vol.29
, Issue.2
, pp. 127-142
-
-
Popovic, M.1
Steinort, D.2
Pillai, S.3
Joukhadar, C.4
-
2
-
-
83655201293
-
Fosfomycin: An old-new antibiotic
-
Raz R. Fosfomycin: an old-new antibiotic. Clin. Microbiol. Infect. 18(1), 4-7 (2012).
-
(2012)
Clin. Microbiol. Infect.
, vol.18
, Issue.1
, pp. 4-7
-
-
Raz, R.1
-
3
-
-
77955646149
-
Fosfomycin versus other antibiotics for the treatment of cystitis: A meta-analysis of randomized controlled trials
-
Falagas ME, Vouloumanou EK, Togias AG et al. Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials. J. Antimicrob. Chemother. 65(9), 1862-1877 (2010).
-
(2010)
J. Antimicrob. Chemother.
, vol.65
, Issue.9
, pp. 1862-1877
-
-
Falagas, M.E.1
Vouloumanou, E.K.2
Togias, A.G.3
-
4
-
-
0031003980
-
Fosfomycin tromethamine A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections
-
Patel SS, Balfour JA, Bryson HM. Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections. Drugs 53(4), 637-656 (1997).
-
(1997)
Drugs
, vol.53
, Issue.4
, pp. 637-656
-
-
Patel, S.S.1
Balfour, J.A.2
Bryson, H.M.3
-
5
-
-
0037299149
-
Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs
-
Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis. Mon. 49(2), 53-70 (2003).
-
(2003)
Dis. Mon.
, vol.49
, Issue.2
, pp. 53-70
-
-
Foxman, B.1
-
6
-
-
42549158593
-
Fosfomycin: Use beyond urinary tract and gastrointestinal infections
-
Falagas ME, Giannopoulou KP, Kokolakis GN, Rafailidis PI. Fosfomycin: use beyond urinary tract and gastrointestinal infections. Clin. Infect. Dis. 46(7), 1069-1077 (2008).
-
(2008)
Clin. Infect. Dis.
, vol.46
, Issue.7
, pp. 1069-1077
-
-
Falagas, M.E.1
Giannopoulou, K.P.2
Kokolakis, G.N.3
Rafailidis, P.I.4
-
7
-
-
34548419669
-
Old antibiotics for infections in critically ill patients
-
Falagas ME, Kopterides P. Old antibiotics for infections in critically ill patients. Curr. Opin. Crit. Care 13(5), 592-597 (2007).
-
(2007)
Curr. Opin. Crit. Care
, vol.13
, Issue.5
, pp. 592-597
-
-
Falagas, M.E.1
Kopterides, P.2
-
8
-
-
72149117149
-
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: A systematic review
-
Falagas ME, Kastoris AC, Kapaskelis AM, Karageorgopoulos DE. Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect. Dis. 10(1), 43-50 (2010).
-
(2010)
Lancet Infect. Dis.
, vol.10
, Issue.1
, pp. 43-50
-
-
Falagas, M.E.1
Kastoris, A.C.2
Kapaskelis, A.M.3
Karageorgopoulos, D.E.4
-
9
-
-
77958193834
-
Treatment of resistant enterococcal urinary tract infections
-
Swaminathan S, Alangaden GJ. Treatment of resistant enterococcal urinary tract infections. Curr. Infect. Dis. Rep. 12(6), 455-464 (2010).
-
(2010)
Curr. Infect. Dis. Rep.
, vol.12
, Issue.6
, pp. 455-464
-
-
Swaminathan, S.1
Alangaden, G.J.2
-
12
-
-
84857646835
-
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance
-
Magiorakos AP, Srinivasan A, Carey RB et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18(3), 268-281 (2012).
-
(2012)
Clin. Microbiol. Infect.
, vol.18
, Issue.3
, pp. 268-281
-
-
Magiorakos, A.P.1
Srinivasan, A.2
Carey, R.B.3
-
13
-
-
68549083465
-
In vitro activity of fosfomycin against ESBL-producing enterobacteria of urinary origin
-
Hernandez MS, Garcia JA, Munoz JL. In vitro activity of fosfomycin against ESBL-producing enterobacteria of urinary origin. Rev. Esp. Quimioter. 22(1), 25-29 (2009).
-
(2009)
Rev. Esp. Quimioter.
, vol.22
, Issue.1
, pp. 25-29
-
-
Hernandez, M.S.1
Garcia, J.A.2
Munoz, J.L.3
-
14
-
-
70349318562
-
Susceptibility of urinary tract bacteria to fosfomycin
-
Maraki S, Samonis G, Rafailidis PI Vouloumanou EK, Mavromanolakis E, Falagas ME. Susceptibility of urinary tract bacteria to fosfomycin. Antimicrob. Agents Chemother. 53(10), 4508-4510 (2009).
-
(2009)
Antimicrob. Agents Chemother.
, vol.53
, Issue.10
, pp. 4508-4510
-
-
Maraki, S.1
Samonis, G.2
Rafailidis, P.I.3
Vouloumanou, E.K.4
Mavromanolakis, E.5
Falagas, M.E.6
-
15
-
-
0141646506
-
In vitro activity of fosfomycin against Gram-negative urinary pathogens and the biological cost of fosfomycin resistance
-
Marchese A, Gualco L, Debbia EA, Schito GC, Schito AM. In vitro activity of fosfomycin against Gram-negative urinary pathogens and the biological cost of fosfomycin resistance. Int. J. Antimicrob. Agents 22(Suppl. 2), 53-59 (2003).
-
(2003)
Int. J. Antimicrob. Agents
, vol.22
, Issue.SUPPL. 2
, pp. 53-59
-
-
Marchese, A.1
Gualco, L.2
Debbia, E.A.3
Schito, G.C.4
Schito, A.M.5
-
16
-
-
67650462781
-
Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: A review of microbiological, animal and clinical studies
-
Falagas ME, Roussos N, Gkegkes ID, Rafailidis PI, Karageorgopoulos DE. Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies. Expert Opin. Investig. Drugs 18(7), 921-944 (2009).
-
(2009)
Expert Opin. Investig. Drugs
, vol.18
, Issue.7
, pp. 921-944
-
-
Falagas, M.E.1
Roussos, N.2
Gkegkes, I.D.3
Rafailidis, P.I.4
Karageorgopoulos, D.E.5
-
17
-
-
0028097111
-
Fosfomycin trometamol and the single-dose treatment of cystitis
-
Greenwood D. Fosfomycin trometamol and the single-dose treatment of cystitis. J. Med. Microbiol. 41(5), 293-294 (1994).
-
(1994)
J. Med. Microbiol.
, vol.41
, Issue.5
, pp. 293-294
-
-
Greenwood, D.1
-
18
-
-
0023133785
-
Activity of Monuril in lower urinary tract infections due to fosfomycin-resistant bacteria
-
Neuman M, Rufin F. Activity of Monuril in lower urinary tract infections due to fosfomycin-resistant bacteria. Eur. Urol. 13(Suppl. 1), 105-107 (1987).
-
(1987)
Eur. Urol.
, vol.13
, Issue.SUPPL. 1
, pp. 105-107
-
-
Neuman, M.1
Rufin, F.2
-
19
-
-
0042424543
-
Biological costs and mechanisms of fosfomycin resistance in Escherichia coli
-
Nilsson AI, Berg OG, Aspevall O, Kahlmeter G, Andersson DI. Biological costs and mechanisms of fosfomycin resistance in Escherichia coli. Antimicrob. Agents Chemother. 47(9), 2850-2858 (2003).
-
(2003)
Antimicrob. Agents Chemother.
, vol.47
, Issue.9
, pp. 2850-2858
-
-
Nilsson, A.I.1
Berg, O.G.2
Aspevall, O.3
Kahlmeter, G.4
Andersson, D.I.5
-
20
-
-
84862936625
-
Fosfomycin: Evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens
-
Karageorgopoulos DE, Wang R, Yu XH, Falagas ME. Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens. J. Antimicrob. Chemother. 67(2), 255-268 (2012).
-
(2012)
J. Antimicrob. Chemother.
, vol.67
, Issue.2
, pp. 255-268
-
-
Karageorgopoulos, D.E.1
Wang, R.2
Yu, X.H.3
Falagas, M.E.4
-
21
-
-
3843049140
-
Inappropriate medication use in older adults: Does nitrofurantoin belong on the list for the reasons stated? Arch
-
Kunin CM. Inappropriate medication use in older adults: does nitrofurantoin belong on the list for the reasons stated? Arch. Intern. Med. 164(15), 1701 (2004).
-
(2004)
Intern. Med.
, vol.164
, Issue.15
, pp. 1701
-
-
Kunin, C.M.1
|